Santhera Pharmaceuticals Holding AG
Stock Forecast, Prediction & Price Target
Santhera Pharmaceuticals Holding AG Financial Estimates
Santhera Pharmaceuticals Holding AG Revenue Estimates
Santhera Pharmaceuticals Holding AG EBITDA Estimates
Santhera Pharmaceuticals Holding AG Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| CHF-1.59M N/A | CHF7.47M 568.52% | CHF103.41M 1283.83% | Avg: CHF36.7M Low: CHF36.7M High: CHF36.7M avg. -64.51% | Avg: CHF70.25M Low: CHF70.25M High: CHF70.25M avg. 91.41% | Avg: CHF130M Low: CHF130M High: CHF130M avg. 85.05% | Avg: CHF158M Low: CHF158M High: CHF158M avg. 21.53% |
Net Income
% change YoY
| CHF-55.52M N/A | CHF-71.07M -28.00% | CHF54.78M 177.07% | Avg: CHF-15.06M Low: CHF-15.06M High: CHF-15.06M avg. -127.50% | Avg: CHF18.52M Low: CHF18.52M High: CHF18.52M avg. 222.96% | Avg: CHF55.35M Low: CHF55.35M High: CHF55.35M avg. 198.79% | Avg: CHF92.85M Low: CHF92.85M High: CHF92.85M avg. 67.74% |
EBITDA
% change YoY
| CHF-43.22M N/A | CHF-42.49M 1.69% | CHF79.17M 286.32% | Avg: CHF-4.23M Low: CHF-4.23M High: CHF-4.23M avg. -105.34% | Avg: CHF-8.10M Low: CHF-8.10M High: CHF-8.10M avg. -91.41% | Avg: CHF-14.99M Low: CHF-14.99M High: CHF-14.99M avg. -85.05% | Avg: CHF-18.22M Low: CHF-18.22M High: CHF-18.22M avg. -21.53% |
EPS
% change YoY
| -$16.25 N/A | -$11.67 28.18% | $5.18 144.38% | Avg: -$1.35 Low: -$1.35 High: -$1.35 avg. -126.06% | Avg: $1.66 Low: $1.66 High: $1.66 avg. 222.96% | Avg: $4.96 Low: $4.96 High: $4.96 avg. 198.79% | Avg: $8.32 Low: $8.32 High: $8.32 avg. 67.74% |
Operating Expenses
% change YoY
| CHF51.52M N/A | CHF55.85M 8.40% | CHF31.33M -43.90% | Avg: CHF-58.85M Low: CHF-58.85M High: CHF-58.85M avg. -287.84% | Avg: CHF-112.66M Low: CHF-112.66M High: CHF-112.66M avg. -91.41% | Avg: CHF-208.49M Low: CHF-208.49M High: CHF-208.49M avg. -85.05% | Avg: CHF-253.40M Low: CHF-253.40M High: CHF-253.40M avg. -21.53% |
FAQ
What is Santhera Pharmaceuticals Holding AG stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 90.49% in 2025-2028.
We have gathered data from N/A analysts. Their low estimate is -15.06M, average is -15.06M and high is -15.06M.
What is Santhera Pharmaceuticals Holding AG stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 33.37% in 2025-2028.
We have gathered data from N/A analysts. Their low revenue estimate is CHF36.7M, average is CHF36.7M and high is CHF36.7M.
What is Santhera Pharmaceuticals Holding AG stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 90.85% in 2025-2028.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$1.35, average is -$1.35 and high is CHF-1.35.